Dipeptidyl peptidase 4 (DPP4) is a molecule implicated in the regulation of metabolic
homeostasis and inflammatory processes, and it exerts its main action through its enzymatic …

OBJECTIVE Comprehensive proteomic profiling of the human adipocyte secretome
identified dipeptidyl peptidase 4 (DPP4) as a novel adipokine. This study assessed the …

Abstract Dipeptidyl peptidase 4 (DPP4) is the target of the gliptins, a recent class of oral
antidiabetics. DPP4 (also called CD26) was previously characterized in immune cells but …

OBJECTIVE To study expression of the recently identified adipokine dipeptidyl peptidase-4
(DPP4) in subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) of patients …

The introduction of dipeptidyl peptidase 4 (DPP4) inhibitors for the treatment of Type 2
diabetes acknowledges the fundamental importance of incretin hormones in the regulation …

Besides a therapeutic target for type 2 diabetes, dipeptidyl peptidase 4 (DPP4) is an
adipokine potentially upregulated in human obesity. We aimed to explore the role of …

Objective Type 1 and 2 diabetes are characterized by elevated blood glucose levels and
increased dipeptidyl peptidase 4 (DPP4) activity levels in the serum. However, previous …

Background: Increase in circulating dipeptidyl peptidase-4 (DPP4) activity and levels has
been reported to associate both with hyperglycemia and obesity. Here we aim to decipher …

Abstract Dipeptidyl-peptidase-4 (DPP-4) is an enzyme having various properties and
physiological roles in lipid accumulation, resistance to anticancer agents, and immune …

Background. The enzyme dipeptidyl peptidase 4 (DPP4) has been recently recognized as
an adipo‐myokine. However, studies that associate its constitutive activity with body …